Hasil Pencarian  ::  Simpan CSV :: Kembali

"Patogenesis nefropati diabetik (ND) merupakan hasil interaksi faktor hemodinamik, metabolik dan lingkungan serta faktor genetik. ND biasanya tidak terdeteksi secara klinis sampai terjadi kerusakan ginjal yang bermakna dapat berupa glomerulosklerosis, tubular atrofi dan fibrosis interstitial. KIM-1 dapat digunakan sebagai penanda adanya kerusakan tubulus ginjal. Hubungan polimorfisme gen ACE dengan nefropati diabetes masih tidak konsisten. Penelitian ini merupakan studi cross sectional komparasi antara dua kelompok penyandang DMT2 dengan atau tanpa nefropati yang bertujuan untuk mengetahui adanya kerusakan tubulus, polimorfisme gen ACE dan menganalisis hubungannya dengan kadar KIM-1 terhadap terjadinya kelainan tubulus. Didapatkan adanya peningkatan ekskresi KIM-1 urin pada 19 subjek pre-nefropati dengan median 1,3 (interquartile 1,5) ng/mL, 25 subjek nefropati insipien dengan median 1,6 (interquartile 2,3) ng/mL dan 12 subjek nefropati overt dengan rerata kadar KIM-1 3,1 ± 2,4 ng/mL. Terdapat polimorfisme gen ACE pada penyandang DMT2. Proporsi genotipe DD 9,3%, ID 33,3% dan II 57,4% pada kelompok NND, pada kelompok ND proporsi genotipe DD 4,7%, ID 34,1% dan genotipe II 61,2%. Dijumpai adanya hubungan bermakna antara alel D dengan peningkatan ekskresi KIM-1 urin pada kelompok pre-nefropati (p = 0,030). Peningkatan kadar KIM-1 urin pada kelompok pre-nefropati menunjukkan adanya kerusakan tubulus yang merupakan proses awal nefropati DM. Distribusi genotipe polimorfisme gen ACE pada penelitian ini menyerupai penelitian lain di negara-negara Asia, sedangkan di negara Eropa genotipe DD lebih banyak daripada genotipe II. Hubungan bermakna alel D dengan kadar KIM-1 hanya pada kelompok prenefropati mungkin disebabkan adanya faktor lain seperti kadar glukosa, kontrol glikemik, ureum, kreatinin dan kadar trigliserida yang memengaruhi. Simpulan: Terdapat peningkatan ekskresi KIM-1 urin pada penyandang DMT2 kelompok pre-nefropati yang meningkat secara bermakna pada penyandang DMT2 dengan nefropati overt. Peningkatan ekskresi KIM-1 urin dapat dipakai sebagai penanda kerusakan tubulus. Terdapat polimofisme gen ACE pada penyandang DMT2. Genotipe II lebih banyak dibanding genotipe ID dan DD. Dijumpai adanya hubungan alel D dengan peningkatan kadar KIM-1 urin pada penyandang DMT2 pre-nefropati.

---

The pathogenesis of nephropathy diabetic (ND) is the result of the interaction of haemodynamic, metabolic, environment, and genetic factors. In general, ND was clinically undetectable until kidney has been damaged significantly, in the form of glomerulosclerosis, tubular atrophy, or interstitial fibrosis. KIM-1 can be used as the initial indicator of kidney tubules damage. The relationship between ACE gene polymorphism and diabetic nephropathy was still inconsistent.

This research was a comparative cross-sectional study on two groups of DMT2 patients with and without nephropathy diabetic. The objectives of this study were to identify the tubules damage, ACE gene polymorphism, and to analyze the relationship between the degree of KIM-1 and the tubules damage. The increase of KIM-1 urine excretion was found in 19 pre-nephropathy subject (median = 1.3 with interquartile 1.5 ng/mL), in 25 incipient nephropathy subject (median = 1.6 (2.3) ng/mL), in 12 overt nephropathy subject (Mean = 3.1 ± 2,4 ng/mL). ACE polymorphism gene was found in DMT2 patients. In the NDD group, the genotype proportion of DD = 9.3%, ID = 33.3% and II = 57.4%. Whereas, in the ND group, the figures were 4.7%, 34.1% and 61.2%, respectively.

Significant relationship was found between allele D and the increase of KIM-1 urine on pre-nephropathy group (p = 0.030). The increase of KIM-1 urine on prenephropathy group shows the tubules damage which is the initial process of nephropathy diabetic. The genotype distribution of ACE gene polymorphism in this study was similar with the studies in Asian countries; however, in European countries the genotype DD is found higher than genotype II. The significant relationship between allele D and KIM-1 level in pre-nephropathy group might be the influence of other factors, such as glucose level, glycaemic control, urea, creatinine, and triglyceride level.

Conclusion: There was KIM-1 excretion increased on DMT2 pre-nephropathy group, which increase significantly in DMT2 overt nephropathy group. The increase of KIM-1 urine excretion can be used as the indicator of tubules damage. ACE gene polymorphism was found in DMT2 group, with genotype II was higher than genotype ID and DD. A significant relationship between allele D and the increase of KIM-1 urine excretion was found in pre-nephropathy group."

"Gangguan fungsi ginjal merupakan salah satu komplikasi yang sering terjadi pada pasien diabetes melitus tipe 2. Pendeteksian dini dengan menggunakan senyawa 8-iso-Prostaglandin F2α dan KIM-1 diperlukan untuk mencegah progresifitasnya. Dalam penelitian ini dilakukan analisis hubungan antara kadar 8-iso-Prostaglandin F2α dan KIM-1 urin dengan estimasi laju filtrasi glomerulus (eLFG). Sampel yang dianalisis adalah 40 orang pasien diabetes melitus tipe 2 di Puskesmas Pasar Minggu, dengan teknik total sampling. Nilai eLFG diperoleh berdasarkan nilai kreatinin serum yang diukur menggunakan metode kinetik Jaffe, sedangkan kadar 8-iso-Prostaglandin F2α dan KIM-1 diukur dengan menggunakan metode ELISA (Enzyme Linked Immunosorbent Assay). Kadar 8-iso-Prostaglandin F2α diperoleh 6633,87 ± 1292,62 pg/mg kreatinin, kadar KIM-1 diperoleh 8,23 ± 3,23 ng/mL dan nilai eLFG diperoleh 99,65 ± 41,12 (Cockroft-Gault); 96,59 ± 41,90 (MDRD study); dan 100,79 ± 40,07 (CKD-EPI). Hubungan antara kadar 8-iso-Prostaglandin F2α dengan nilai eLFG berdasarkan persamaan Cockroft-Gault (r = 0,520; p = 0,001), MDRD (r = 0,477; p = 0,004) dan CKD-EPI (r = 0,403; p = 0,013), serta setelah perokok dieksklusi, berdasarkan ketiga persamaan, yaitu Cockroft-Gault (r = 0,595; p = 0,001), MDRD (r = 0,554; p = 0,003) dan CKD-EPI (r = 0,559; p = 0,003). Hubungan antara kadar KIM-1 dengan nilai eLFG berdasarkan persamaan Cockroft-Gault (r = -0,155; p = 0,339), MDRD (r = -0,173; p =0,285) dan CKD-EPI (r = -0,024; p = 0,883). Sehingga diketahui terdapat hubungan yang bermakna antara kadar 8-iso-Prostaglandin F2α dengan nilai eLFG dan tidak terdapat hubungan yang bermakna antara KIM-1 dengan nilai eLFG.

---

Renal dysfunction is one of complication that most common in type 2 diabetes mellitus patients. The earlier detection is needed to prevent its progression with 8-iso-Prostaglandin F2α and KIM-1. The aim of this study was to analyze concentration of 8-iso-Prostaglandin F2α and KIM-1urine and its correlation with estimated glomerular filtration rate (eGFR). Samples analyzed were 40 type 2 diabetes mellitus patients at Pasar Minggu Local Government Clinic, used total sampling method.

eGFR was obtained based on the measurement of serum creatinine on kinetic Jaffe method, 8-iso-Prostaglandin F2α and KIM-1 was measured by ELISA (Enzyme Linked Immunosorbent Assay) method. Concentration of 8-iso-Prostaglandin F2α was 6633,87 ± 1292,62 pg/mg creatinine, concentration of KIM-1 was 8,23 ± 3,23 ng/mL and the eGFR values were 99,65 ± 41,12 (Cockroft-Gault); 96,59 ± 41,90 (MDRD study); and 100,79 ± 40,07 (CKD-EPI).

The correlation between 8-iso-Prostaglandin F2α concentration and eGFR is based on Cockroft-Gault (r = 0,520; p = 0,001), MDRD (r = 0,477; p = 0,004) and CKD-EPI (r = 0,403; p = 0,013), and the correlation between 8-iso-Prostaglandin F2α concentration after smoker exclution and eGFR based on Cockroft-Gault (r = 0,595; p = 0,001), MDRD (r = 0,554; p = 0,003) and CKD-EPI (r = 0,559; p = 0,003). But the correlation between KIM-1 concentration and eGFR based on Cockroft-Gault (r = -0,155; p = 0,339), MDRD (r = -0,173; p =0,285) and CKD-EPI (r = -0,024; p = 0,883). So there was a significant correlation between 8-iso-Prostaglandin F2α concentration and eGFR, and also there were no significant correlation between KIM-1 concentration and eGFR."

"Menurut hasil Riset Kesehatan Dasar yang dilakukan pada tahun 2018, prevalensi prediabetes adalah 57,1%. Prediabetes merupakan faktor risiko hiperfiltrasi ginjal yang dapat memicu kerusakan ginjal. Meskipun vitamin D umumnya tidak digunakan dalam tatalaksana hiperglikemia, efek anti-inflamasi, anti fibrotik dan mekanisme umpan balik pada sistem renin-angiotensin vitamin D dapat bermanfaat dalam tatalaksana prediabetes. Efek protektif terapi vitamin D terhadap kerusakan ginjal akut pada kondisi prediabetes perlu diteliti lebih lanjut. Penelitian ini adalah penelitian eksperimental pada model hewan yang menggunakan sampel urin tersimpan dari penelitian sebelumnya. Tikus dikelompokan dalam kelompok sehat, kelompok prediabetes, kelompok prediabetes dengan pemberian vitamin D 100 IU/kg BB/hari atau kelompok prediabetes dengan pemberian vitamin D 1000 IU/kg BB/hari. Sebanyak 6 ekor tikus dalam setiap kelompok diteliti selama 12 minggu. KIM-1 diukur dengan metode ELISA dan dianalisis menggunakan analisis uji One-way ANOVA. Terdapat peningkatan kadar KIM1 pada tikus prediabetes. Pemberian terapi vitamin D3 dosis 100 IU/kg BB/hari dan 1,000 IU/kg BB/hari menurunkan kadar KIM-1 jika dibandingkan dengan tikus model prediabetes yang tidak mendapatkan terapi vitamin D3. Namun, hanya vitamin D3 dosis 1,000 IU/kg BB/hari yang menurunkan kadar KIM-1 pada tikus model prediabetes secara bermakna (p = 0,043).

---

According to the Riset Kesehatan Dasar in 2018, the prevalence of prediabetes was 57.1%. Prediabetes is a risk factor for renal hyperfiltration that can lead to kidney damage. Although vitamin D is not generally used to treat hyperglycemia, its anti-inflammatory effect, anti-fibrotic effect and feedback mechanisms on the renin-angiotensin system may be useful in the management of prediabetes. Therefore, the protective effect of vitamin D therapy against acute kidney damage in prediabetes conditions is worthy of investigation. This study is an experimental study using stored urine samples from a previous study. Rats were grouped into the healthy group, the prediabetes group, the prediabetes group which received 100 IU/kg BW/day of vitamin D or the prediabetes group which received 1000 IU/kg BW/day of vitamin D. Each group had 6 rats and were studied for 12 weeks. KIM-1 was measured by ELISA and analyzed using the One-way ANOVA test. There was an increase in KIM-1 levels in prediabetic rats. Administration of vitamin D3 therapy at doses of 100 IU/kg BW/day and 1000 IU/kg BW/day reduced KIM-1 levels when compared to prediabetic rats which did not receive vitamin D3 therapy. However, only 1000 IU/kg BW/day of vitamin D significantly (p=0.043) reduced KIM-1 levels in prediabetic rats."

"Latar belakang Sisplatin merupakan pengobatan utama untuk karsinoma nasofaring KNF , tetapi berpotensi menimbulkan nefrotoksisitas. Selain kadar BUN dan kreatinin serum, KIM-1 dan NGAL diduga cukup sensitif untuk mendeteksi nefrotoksisitas. Penelitian ini bertujuan untuk mengevaluasi kadar KIM-1 dan NGAL dalam urin untuk mendeteksi gangguan fungsi ginjal pada pasien KNF stadium lanjut yang mendapatkan kemoterapi berbasis sisplatin.Metode: Penelitian ini merupakan penelitian kohort prospektif. Subyek penelitian dibagi dalam 3 kelompok: pasien yang belum pernah terpapar dan yang sudah pernah mendapatkan kemoterapi berbasis sisplatin 75-100 mg/m serta pasien yang belum pernah mendapatkan kemoterapi sisplatin dan kemudian diberi sisplatin 40 mg/m 2 . Kadar KIM-1, NGAL dalam urin serta kadar BUN dan kreatinin dalam serum diukur pada saat sebelum dan sesudah mendapatkan sisplatin pada ketiga kelompok. Analisis statistik yang digunakan adalah uji ANOVA, uji Pearson, Spearman, Kolmogorov-Smirnov dan SPSS versi 22,0.Hasil: Terdapat perbedaan selisih kadar BUN yang bermakna antara sebelum dan sesudah diterapi pada ketiga kelompok p=0.0001 . Perbedaan selisih kadar NGAL dalam urin pada penelitian ini juga berbeda bermakna antara sebelum dan sesudah diterapi terhadap ketiga kelompok p=0,025 , tetapi ada perbedaan rerata pada sepasang kelompok yang bermakna hanya didapatkan pada kelompok yang belum pernah dikemoterapi 40 mg/m 2 dan kelompok yang sudah pernah diberi kemoterapi 75-100 mg/m 2 p=0,02. Perbedaan selisih kadar KIM-1 tidak bermakna pada ketiga kelompok p=0,275.Kesimpulan: Sisplatin menunjukkan akumulasi nefrotoksisitas yang tergantung pada dosis dose-dependent manner . Pengukuran kadar NGAL dalam urin dapat mendeteksi nefrotoksisitas tahap dini, tetapi belum bisa menggantikan peran BUN. Pengukuran kadar KIM-1 dalam urin tidak dapat mendeteksi gangguan fungsi ginjal.

---

Background: Cisplatin is the main treatment for nasopharyngeal carcinoma NPC with a potency of causing nephrotoxicity. In addition to serum BUN and creatinine levels, KIM 1 and NGAL levels is assumed to be quite sensitive in detecting nephrotoxicity. The study was aimed to evaluate urinary KIM 1 and NGAL level to detect kidney dysfunction in patients with advanced stage NPC who received cisplatin based chemotherapy.

Method: The study was a cohort prospective study. Subjects were categorized into 3 groups, i.e. patients who had never received and who had received 75 100 mg m2 cisplatin based chemotherapy as well as those who had never received any cisplatin based chemotherapy and were subsequently received 40 mg m cisplatin. The levels of urinary KIM 1, NGAL and serum level of BUN and creatinine were measured before and after receiving cisplatin in the three groups. Statistical analysis used in our study were ANOVA, Pearson, Spearman, KolmogorovSmirnov test and SPSS version 22.0.

Results: There was a significant difference of delta BUN level before and after treatment in all three groups p 0.0001 . Delta urinary NGAL level was also significantly different between before and after treatment in all groups p 0.025 however, a significant mean difference of a pair group was only found between those who never had 40 mg m 2 chemotherapy and those who had received 75 100 mg m 2 chemotherapy p 0.02 while delta KIM 1 level showed no significant difference in all three groups p 0.275.

Conclusion: Cisplatin may cause accumulated nephrotoxicity, which has dosedependent manner. Measuring urinary NGAL level can detect an early stage of kidney dysfunction however, it still cannot replace the role of BUN. Measurement of urinary KIM 1 level cannot detect kidney dysfunction."

"ABSTRAKLatar belakang: Sepsis merupakan masalah kesehatan penting yang dapat menyebabkan insidens kematian sampai 50% pada pasien dengan sepsis berat. Antibiotik aminoglikosidaterutama amikasin semakin banyak digunakan untuk mengobati infeksi kuman Gram negatif pada pasien sepsis di ICU, meskipun penggunaan obat tersebut pada dosisterapi dapat meningkatkan risiko kerusakan ginjal sekitar 10-25%. Pemantauan kadar lembah amikasin serta biomarker dini diperlukan untuk mencegah kerusakan ginjal pada pasien sepsis yang dirawat di ICU. Penelitian ini dilakukan untuk mengetahui hubungan kadar lembah amikasin pada pasien ICU dewasa yang dirawat di Rumah Sakit Cipto Mangunkusumo yang diberikan amikasin 1000 mg/hari denganpeningkatan kadar KIM-1 normalisasi dalam urin yang merupakan biomarker dini nefrotoksisitas.Metode:Penelitian ini merupakan penelitian pendahuluan yang dilakukan pada 12 pasien sepsis dewasa yang dirawat di ICU RSCM dan diberikan amikasin 1000 mg/hari pada bulan Mei-September 2015. Kadar lembah amikasin dosis ketiga dihubungkan dengan peningkatan kadar KIM-1 normalisasi yang diukur melalui urin 24 jam setelah pemberian amikasin dosis pertama/kedua dan dosis ketiga.Hasil:Dari 12 subyek penelitian, didapatkan 3 subyek penelitian dengan kadar lembah amikasin di atas 10 g/mL, sedangkan 9 subyek penelitian kadar lembahnya ada dalam batas aman (di bawah 10 g/mL). Delapan dari 12 subyek penelitian (66,7%) mengalami peningkatan kadar KIM-1 normalisasi dalam urin hari ketiga dibandingkan hari pertama. Tidak ada hubungan antara kadar lembah amikasin dengan peningkatan kadar KIM-1 normalisasi dalam urin (p=0,16; r=0,43).Kesimpulan:Pasien sepsis yang mendapat amikasin 1000 mg/hari di ICU RSCM selama 3 hari memperlihatkan kadar lembah amikasin plasma dalam batas aman untuk ginjal.

---

ABSTRACT

Background: Sepsis is a common caused of mortality which may account for up to 50% death rate in patients with severe sepsis. Aminoglycoside antibiotics, especially amikacin, are the most commonly used antibiotics in the septic patients with Gram-negative bacterial infections, despite these drugs may induce nephrotoxicity in 10-25%

patients. Hence, it is essential to monitor amikacin trough plasma concentration and to detect nephrotoxicity as early as possible. The aim of this study is to find out the correlation between amikacin trough plasma concentration with normalized KIM-1 concentration in the urine as a sensitive and specific biomarker.

Methods:

This is a pilot study conducted in 12 septic patients treated with amikacin 1000 mg/day from May, 2015 to September, 2015. The correlation between amikacin

trough plasma concentrations measured at the third doses with the elevation of urine normalized KIM-1 concentrations measured at the first/second and the third doses were evaluated.

Results:

We observed 3 patients with amikacin trough plasma concentration above the safe level (>10 g/mL), while 9 patients had amikacin concentrations within the safe

plasma level (<10 g/mL). Furthermore, we observed 8 out of 12 patients with higher normalized KIM-1 concentrations measured at third doses compared to normalized KIM-1 concentrations measured at first/second doses. There was no correlation between amikacin trough concentration with elevated urine normalized KIM-1

concentration (p=0,16; r=0,43).

Conclusion:

Septic patients treated with amikacin 1000 mg/day hospitalized in ICU RSCM for 3 days have amikacin safe trough plasma concentration."

"Pemantauan terapi obat adalah kegiatan untuk memastikan terapi obat yang aman, efektif, dan rasional bagi pasien dengan mengkaji pemilihan obat, dosis, cara pemberian obat, respons terapi, reaksi obat yang tidak dikehendaki, dan rekomendasi perubahan atau alternatif terapi. Kondisi pasien yang perlu dilakukan pemantauan terapi obat antara lain pasien hamil dan menyusui, pasien yang menerima regimen yang kompleks (polifarmasi) serta pasien geriatri dan pediatri. Tujuan laporan PKPA ini adalah untuk menganalisa dan mengevaluasi drug related problem (DRP) pada pasien dan diklasifikasikan sesuai kategori Hepler dan Strand. Kegiatan dilakukan melalui pengambilan data pasien dengan diagnosis syok kardiogenik dengan gagal jantung, gangguan ginjal akut, DM tipe 2, dan hipokalemia. Data yang diambil merupakan kombinasi data primer dan sekunder. Berdasarkan hasil analisis, diketahui bahwa pengobatan yang diterima oleh pasien hampir seluruhnya tepat indikasi dan dosis kecuali dosis pada sukralfat dan allopurinol yang melebihi rentang dosis seharusnya. Selain itu, ditemukan DRP berupa interaksi obat yang bersifat potensial, pemilihan obat tidak tepat, serta indikasi tanpa obat. DRP tersebut telah diatasi dengan pemberian terapi yang sesuai.

---

Drug therapy monitoring is an activity to ensure safe, effective, and rational drug therapy for patients by reviewing the selection of drugs, dosages, methods of drug administration, therapeutic response, unwanted drug reactions, and recommendations for changes or alternative therapies. Patients who need to be monitored for drug therapy include pregnant and lactating patients, patients receiving complex regimens (polypharmacy), as well as geriatric and pediatric patients. The purpose of this PKPA report is to analyze and evaluate drug-related problems (DRP) in patients and classify them according to the Hepler and Strand categories. Activities are carried out through the data collection of patients with a diagnosis of cardiogenic shock with heart failure, acute kidney disorder, type 2 DM, and hypokalemia. The data was took is a combination of primary and secondary data. Based on the results of the analysis, it was known that the treatment received by the patients was almost entirely in accordance with the right indication and dosage, except for the doses of sucralfate and allopurinol, which exceeded the proper dosage range. In addition, DRP was found in the form of potential drug interactions, inappropriate drug selection, and indications without drugs. The DRP has been overcome by administering appropriate therapy."

"Diabetes mellitus DM dapat menyebabkan kerusakan ginjal dan nefropati diabetik merupakan penyebab gagal ginjal tersering. Penelitian ini bertujuan untuk mengetahui jumlah sel epitel tubulus ginjal dalam sedimen urin yang dapat dijadikan penanda kerusakan ginjal pada penderita DM. Penelitian ini juga bertujuan mencari nilai cut off jumlah sel epitel tubulus ginjal sebagai penanda kerusakan ginjal pada penderita DM, korelasi antara jumlah sel epitel tubulus ginjal dengan urine albumin/creatinine ratio UACR dan ?2-microglobulin urin serta korelasi antara ?2-microglobulin serum dengan UACR. Desain penelitian adalah potong lintang deskriptif analitik dengan 90 subjek, penelitian berlangsung selama Juni hingga Oktober 2017. Sampel menggunakan urin dan serum penderita diabetes mellitus. Jumlah sel epitel tubulus ginjal diperiksa dengan Sysmex UF-4000. Kadar albumin urin diperiksa dengan NycoCard. Kadar ?2-microglobulin serum dan urin serta kreatinin urin diperiksa dengan Cobas C501. Hasil penelitian didapatkan perbedaan bermakna jumlah sel epitel tubulus ginjal pada kelompok nefropati diabetik dengan non nefropati diabetik 2,4 sel /?L vs 1,6 sel /?L . Tidak ada korelasi antara jumlah sel epitel tubulus ginjal dengan UACR dan ?2-microglobulin urin. Korelasi antara ?2-microglobulin serum dengan UACR adalah lemah dan bermakna.

---

Diabetes mellitus DM can cause kidney damage and diabetic nephropathy is the most common cause of renal failure. This study aimed to determine the number of renal tubular epithelial cells in urine sediments that could be used as a marker of kidney damage in patients with DM. This study also aimed to determine cut off point of renal tubular epithelial cells as a marker of kidney damage in patients with DM, the correlation between the renal tubular epithelial cells with urine albumin creatinine ratio UACR and 2 microglobulin urine and the correlation between serum 2 microglobulin and UACR.

The study design was cross sectional, descriptive analytic with 90 subjects, the study took place during June to October 2017. The sample used urine and serum of diabetic patients. The renal tubular epithelial cells was examined with Sysmex UF 4000. Urinary albumin levels are determined with NycoCard. Serum 2 microglobulin and urine and urinary creatinine levels were determined with Cobas C501.

The results showed significant differences in number of renal tubular epithelial cells in the diabetic nephropathy group with non diabetic nephropathy 2.4 cells L vs. 1.6 cells L . There was no correlation between the number of renal tubular epithelial cells with UACR and urine 2 microglobulin. The correlation between serum 2 microglobulin with UACR was weak and significant."

"Penyakit Ginjal Diabetes (PGD) merupakan salah satu komplikasi mikrovaskular dari penyakit Diabetes Melitus Tipe 2 (DMT2) yang cenderung tidak terdeteksi secara dini sehingga diperlukan biomarker yang lebih efektif untuk mendeteksi penyakit ini. Tingginya HbA1c diketahui berpengaruh pada progresivitas PGD karena berkaitan dengan penurunan laju filtrasi glomerulus (eGFR) dan peningkatan rasio albumin kreatinin urin (UACR). Penelitian ini merupakan studi metabolomik tidak tertarget dan bertujuan untuk membandingkan metabolit urin pasien DMT2 risiko PGD rendah dengan HbA1c terkontrol dan tidak terkontrol pada pasien yang mengonsumsi terapi metformin-glimepirid. Penelitian dilakukan dengan desain potong lintang dengan teknik pengambilan sampel non-probabilitas di Puskesmas Kecamatan Pasar Minggu. Sebanyak 32 sampel dibagi menjadi dua kelompok, yakni kelompok HbA1c terkontrol (n=16) dan kelompok HbA1c tidak terkontrol (n=16). Sampel darah diambil untuk pengukuran HbA1c dan eGFR sedangkan sampel urin diambil untuk pengukuran UACR dan dianalisis metabolitnya. Analisis metabolit dilakukan menggunakan LC/MS-QTOF dan diolah datanya menggunakan MetaboAnalyst 6.0 serta berbagai database. Signifikansi metabolit antarkelompok diseleksi dengan parameter VIP>1, log2(FC)>1,2, dan p-value<0,05. Tiga metabolit yang berpotensi menjadi biomarker (AUC>0,65), yaitu oxaloacetate, 5'-phosphoribosyl-N-formylglycinamidine, dan (S)-dihydroorotate. Berdasarkan ketiga metabolit tersebut, jalur metabolisme yang terlibat meliputi (1) alanin, aspartat, dan glutamat, (2) asam sitrat (siklus Krebs), (3) glukoneogenesis, (4) piruvat, (5) pirimidin, dan (6) purin.

---

Diabetic Kidney Disease (DKD) is one of the microvascular complications of Type 2 Diabetes Mellitus (T2DM) which tended not to be detected early, necessitating more effective biomarkers for its detection. Uncontrolled HbA1c was significantly associated with the progression of DKD because it is associated with a decrease in glomerular filtration rate (eGFR) and an increase in the urine albumin creatinine ratio (UACR). This study was an untargeted metabolomics study and aimed to compare urine metabolites in low-risk DKD T2DM patients with controlled and uncontrolled HbA1c undergoing metformin-glimepiride therapy. Conducted with a cross-sectional design and non-probability sampling at Pasar Minggu District Health Center, 32 samples were split into controlled (n=16) and uncontrolled HbA1c groups (n=16). Blood samples were taken for measurement of HbA1c and eGFR, while urine samples were taken for measurement of UACR and analyzed for metabolites. Metabolite analysis was carried out using LC/MS-QTOF and the data were processed using MetaboAnalyst 6.0 and various databases. Significant metabolites were identified with VIP>1, log2(FC)>1.2, and p-value<0.05. Three metabolites, namely oxaloacetate, 5'-phosphoribosyl-N-formylglycinamidine, and (S)-dihydroorotate, emerged as potential biomarkers (AUC>0.65). The involved metabolic pathways included (1) alanine, aspartate, and glutamate, (2) citric acid (Krebs cycle), (3) gluconeogenesis, (4) pyruvate, (5) pyrimidine, and (6) purine."

"Disfungsi ginjal adalah salah satu komplikasi kronik pada pasien diabetes melitus tipe 2 DM tipe 2 yang diketahui sebagai nefropati diabetik. Salah satu penanda yang digunakan sebagai pendeteksi kerusakan ginjal adalah rasio albumin kreatinin UACR. Selain UACR, kolagen tipe IV banyak diteliti terkait fungsinya sebagai pendeteksi awal nefropati diabetik. Tujuan penelitian ini adalah untuk menilai perbedaan UACR, kadar kolagen tipe IV urin, serta mengetahui hubungan keduanya pada pasien yang menerima terapi angiotensin-converting enzyme inhibitors ACEI dan angiotensin receptor blockers ARB sebagai kelas yang menghambat perkembangan nefropati diabetik pada pasien DM tipe 2. Penelitian dilakukan dengan menggunakan studi cross sectional dan teknik pengambilan consecutive sampling. Terdapat dua kelompok dalam penelitian ini, pasien dengan terapi ACEI n = 14 dan ARB n = 26. Kolagen tipe IV urin dianalisis dengan menggunakan ELISA kit. Albumin dan kreatinin urin diukur dengan menggunakan metode imunoturbidimetri dan kolorimetri. Kadar kolagen tipe IV urin dihitung dengan normalisasi pengukuran kolagen tipe IV urin dengan kadar kreatinin urin. Pada nilai UACR, rerata kedua kelompok ACEI = 276,61 65,119 g/mg kreatinin urin; ARB = 87,25 24,743 g/mg kreatinin urin menunjukkan perbedaan bermakna p = 0,019, kedua kelompok ACEI = 117,14 37,36 ng/mg kreatinin urin; ARB = 14,19 1,46 ng/mg kreatinin urin juga menunjukkan perbedaan bermakna pada kadar kolagen tipe IV urin p < 0,001. Uji korelasi antara nilai UACR dan kadar kolagen tipe IV urin menunjukkan hubungan moderat pada kedua kelompok penelitian r = 0,489; p = 0,001. Hasil menunjukkan bahwa kelompok ARB memiliki tingkat kolagen tipe IV urin yang lebih rendah dibandingkan dengan ACEI, sehingga terapi dengan ARB kemungkinan dapat menghambat perkembangan nefropati diabetik.

---

Renal dysfunction is one of chronic complications in type 2 diabetes mellitus patients T2DM known as diabetic nephropathy DN. Urine albumin creatinine ratio UACR is a widely used test for detection of DN. Beside of UACR, type IV collagen has been studied to its function as an early detection of DN. The aim of this study was to compare differences in UACR, urinary type IV collagen, and their correlation in patients with angiotensin converting enzyme inhibitors ACEI versus angiotensin receptor blockers ARB treatment as classes with respect to delay the development of DN in patients with type 2 diabetes by using cross sectional study and consecutive sampling method. There were 2 groups in this study, patients with ACEI n 14 and ARB therapy n 26. Urinary type IV collagen were analyzed using ELISA kit. Urine albumine and urine creatinine was measured by using immunoturbidimetry and colorimetric method. Urinary type IV collagen levels were calculated by normalizing type iv collagen with urine creatinine levels. Results showed that UACR ACEI 276,61 65,119 g mg urine creatinine ARB 87,25 24,743 g mg urine creatinine showed significant differences p 0.019, urinary type IV collagen ACEI 117,14 37,36 ng mg urine creatinine ARB 14,19 1,46 ng mg urine creatinine showed significant differences p 0.001. Correlation between UACR and urinary type IV collagen presented a moderate correlation in both studied groups r 0.489 p 0.001. The results showed that group with ARB treatment have lower level of urinary type IV collagen compared to groups with ACEI treatment, conclude that ARB more likely to inhibit the development of DN."

"Latar belakang:Luka bakar derajat berat merupakan trauma dengan morbiditas dan mortalitas yang tinggi. Salah satu komplikasi pada luka bakar derajat berat yang sering ditemui adalah gangguan ginjal akut (GGA) dan ketidakseimbangan elektrolit. Hal ini menyebabkan hiperkatabolisme yang berkepanjangan dan berujung pada malnutrisi. Terapi medik gizi yang komprehensif dan holistik diperlukan untuk mencegah bertambahnya progresivitas penyakit dan malnutrisi yang memengaruhi kualitas hidup pasien.Kasus:Pada serial kasus ini terdapat 4 pasien laki-laki, berusia 37-70 tahun dengan diagnosis luka bakar derajat II-III, 24-79% LPT yang disebabkan karena api dan listrik. Status nutrisi pasien bervariasi dari berat badan normal hingga obes 2. Target pemberian nutrisi berdasarkan rekomendasi ESPEN SCCM dan ASPEN untuk pasien kritikal dan luka bakar. Namun, kebutuhan nutrisi disesuaikan dengan kondisi klinis, data laboratorium, dan toleransi asupan harian.Hasil:Selama perawatan, seluruh pasien memiliki riwayat asupan energi total <35 kkal/kgBB dan protein <1,5 g/kgBB Tiga pasien menjalani hemodialisis suportif. Terapi medik gizi diberikan sesuai kondisi klinis pasien dengan target protein 0,8-1 g/kgBB/hari pada GGA tanpa dialiasis dan 1-1,5 g/kgBB/hari dengan dialisis. Terapi nutrisi juga menyesuaikan ketidakseimbangan elektrolit pada pasien. Penurunan berat badan pada keempat kasus <10% selama perawatan. Mikronutrien diberikan untuk penyembuhan luka namun dosis menyesuaikan dengan fungsi ginjal.Kesimpulan:Terapi medik gizi yang adekuat mencegah progresivitas penyakit dan malnutrisi pada pasien luka bakar derajat berat dengan GGA dan ketidakseimbangan elektrolit.

---

Background:

Severe burn injury is a trauma with a serious morbidity and mortality. One of the most complication in severe burn injury is acute renal injury (AKI) and electrolyte imbalance. They could cause a prolonged hypercatabolism that susceptible to develop malnutrition. Comprehensive and holistic nutritional medical therapy is needed to prevent development or rapid progression of malnutrition which affects the quality of life of patients.

Methods:

The case series consists of four men, aged 37-70 years with a diagnosis of severe burn injury, degree II-III, 24-79% of TBSA caused by fire and electricity. The nutritional status of patients varies from normal body weight to obese 2. Target of nutrition based on ESPEN SCCM and ASPEN recommendation for critical and burn patients. However, nutritional requirements are adjusted according to clinical conditions and daily intake tolerance.

Results:

All patients had a history of total energy intake <35 kcal/kgs with protein <1.5 g/ kgs. Three of them underwent supportive hemodialysis. Nutritional medical therapy was given according to the clinical condition of each patient with a protein target of 0.8 -1 g/kgs/day in AKI without dialysis and 1-1.5 g/kgs/day on dialysis. Nutritional therapy also adjusts for electrolyte imbalances. Weight loss in all four cases <10% during treatment. Micronutrients are given for wound healing but the dosage adjusts to kidney function.

Conclusions:

Adequate nutritional medical therapy in severe burn injury with AKI and electrolyte imbalance preventing development of rapid progression of malnutrition in critical ill patient."